Ventus Therapeutics Funding & Investors
Waltham, MA
Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases, and cancer. Ventus' structural immunology platform offers unprecedented insight into mechanisms and molecular structures, combining core capabilities for precisely targeting the innate immune system: proprietary protein engineering capabilities that elucidate innate immune mechanisms, and leading-edge rational and structure-based drug design tools. Ventus has built an emerging pipeline of multiple drug programs addressing key targets in the innate immune system.
ventustx.comTotal Amount Raised: $370,150,016
Ventus Therapeutics Funding Rounds
Grant
$150,000
Grant Investors
Michael J Fox FoundationCorporate Round
$70,000,000
Corporate Round Investors
Novo NordiskSeries C
$140,000,000
Series C Investors
Ra Capital ManagementSoftBank Vision FundAlexandria Venture InvestmentsQatar Investment AuthorityGVBiotechnology Value FundCasdin CapitalFonds de solidarité FTQCormorant Asset ManagementVersant VenturesAndreessen HorowitzSeries B
$100,000,000
Series B Investors
Ra Capital ManagementAlexandria Venture InvestmentsGVBiotechnology Value FundCasdin CapitalVersant VenturesFonds de solidarité FTQCormorant Asset ManagementSeries A
$60,000,000
Series A Investors
Versant VenturesGV